By Tierney Sneed, Sarah Owermohle, CNN
(CNN) — As thousands of protestors demonstrate in Washington, DC, at Friday’s annual March for Life, the Trump administration faces a deadline to explain why it opposes a lawsuit that would achieve a key goal of its allies in the anti-abortion movement by ending the availability of abortion pills by mail.
The lawsuit, brought by Louisiana against the President Donald Trump-appointed health officials, is one of several pressure points the anti-abortion movement is pressing to push the administration to limit access to medication abortion, which now accounts for roughly two-thirds of all abortions in the United States.
“We’re at a point where, from a lot of the pro-life movement’s perspective, this is too important to play political games with,” Katie Glenn Daniel, the director of legal affairs for SBA Pro-Life America, told CNN. “They could pull these drugs out of the mail tomorrow. The justification is more than there.”
While Trump has erected some hurdles to abortion in his second term, his administration has not reversed regulatory rules that have allowed abortion pills to be sent by the mail. That policy, enacted under President Joe Biden, has made it possible for women within states that limit of ban abortion to obtain the two-step drug regimen used to terminate a pregnancy.
Trump health officials promised to look at the drug’s safety data, but they have been noncommittal about when that would happen, or if they would ultimately reverse the Biden-era changes.
“Where we are is that that the Trump administration has managed not to say anything,” said Mary Ziegler, a law professor at UC-Davis and author of several books about the anti-abortion movement. “It seems pretty clear politically that all the steps that Republicans and abortion opponents are taking aren’t really moving the administration.”
Anger within the anti-abortion community over the lack of action has reached a fever pitch and is manifesting in lawsuits, congressional hearings and calls for the firing of a top Trump appointee.
“We can simply fix this if we have the courage to do it,” Sen. Lindsey Graham, a South Carolina Republican and staunch Trump ally, said last week. “So, what all of us are telling the administration: ‘you’ve been a very pro-life president, Mr. President, it’s now time to deal with this issue.’”
The White House, which did not respond to CNN’s inquiry, is this week announcing new anti-abortion measures related to federal funding, including an expansion of a policy that bars foreign aid to groups that promote abortion. But SBA-List said that addressing abortion drugs was an “urgent” issue the administration must act on.
“If there are those that don’t care about the life issue, they should care about the politics of this,” said Tony Perkins, president of Family Research Council. “This is going to be a political problem for those who have sold out the pro-life movement.”
Ire directed at Trump health officials
At a Senate hearing last week that aired GOP grievances about how medication abortion was reaching states that had banned the procedure, Republicans made clear that they had lost patience with the administration.
“Republican members of this committee and many other senators expect an answer,” said Louisiana Sen. Bill Cassidy, the chair of the committee on Health, Education, Labor and Pensions. “At an absolute minimum, the previous in-person safeguards should be restored and that should be done immediately.”
Health and Human Services Secretary Robert F. Kennedy Jr said in a September letter to Republican attorneys general that he had ordered drug regulators to “review the latest data” on mifepristone’s risks and safety. But Kennedy and agency spokespeople did not say when the review began or how long it would take.
Abortion advocates and mifepr